Article
Modeling the evolution of drug resistance in malaria.
Journal of computer-aided molecular design - 1 Dec 2012
Hecht David, Fogel Gary B
Abstract excerpt
Plasmodium falciparum, the causal agent of malaria, continues to evolve resistance to frontline therapeutics such as chloroquine and sulfadoxine-pyrimethamine. Here we study the amino acid replacements in dihydrofolate reductase (DHFR) that confer resistance to pyrimethamine while still binding the natural DHFR substrate, 7,8-dihydrofolate, and cofactor, NADPH. The chain of amino acid replacements that has led to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
